Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPPatrizia Pregno, Umberto Vitolo, Luca Vaggelli et al.|Blood|2012Cited by 238
Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP.Patrizia Pregno, Umberto Vitolo, Simone Ferrero et al.|Blood|2009Cited by 12
The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy.Umberto Vitolo, G Bisi, Chiara Frairia et al.|Blood|2010Cited by 4
Impact of radioguided occult lesion localization in the management of cervical recurrences from differentiated thyroid cancerV. Garbaccio, R. Pellerito, Monica Finessi et al.|The Quarterly Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 3
Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?Francesca Giunta, G Bisi, Umberto Vitolo et al.|PubMed|2015Cited by 3